Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant Chaturbhuj Bhutada SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kanatabai Inani
Shilpa Medicare top gainer after sharp falls, but red flags remain
Pharma company Shilpa Medicare had a bumpy August, with share prices falling to a five year low to Rs. 210 on August 29 from Rs. 360 earlier that month. The trigger was weak Q1 results for the company, with falls in revenue and net profit both YoY and QoQ. The company also got smacked with five FDA observations for its Raichur plant - including the observation that during a plant walkthrough, the plant experienced three power cuts within fifteen minutes. The backup generator was during this time, unable to restore power. The FDA had also noted insufficient cleaning of utensils, missing equpment, etc. Shilpa Medicare in its filing to the exchanges referred to these observations as procedural. The company's sharp price fluctuations recently received clarification requests from the BSE. Investors should exercise caution. SHILPA MEDICARE LTD. - 530549 - Shilpa Medicare Limited Has Fixed Book Closure For Declaration Of Dividend And Conduct Of 32Nd Annual General Meeting To Be Held On 20Th September, 2019
This is to inform you that the Share transfer and register of members of the company would be closed as under Starting of book closure: 14.09.2019 Ending of book closure: 20.09.2019 Purpose: Declaration of Dividend and conduct of 32nd Annual General Meeting to be held on 20th September, 2019 This is for your information and record. Shilpa Medicare Ltd - 530549 - Intimation Under Regulation 47 Of SEBI (LODR) 2015
Notice is hereby given that: 1) The 32nd Annual General Meeting of the members of Shilpa Medicare limited is scheduled to be held on Friday the 20th day of September, 2019 at 12:15 P.M. at registered office of the company being #12-6-214/A-1, Shilpa House, Hyderabad Road, Raichur - 584135, Karnataka, India to transact the business as set out in the notice dated 13th August, 2019. 2) Notice and Annual report 2018-19 have been sent to all those members whose emails are registered with Registrar and Share transfer agent. The dispatch of the notice has been completed on 29.08.2019. 3)It is further stated that the Transfer books of the company would be closed from 14.09.2019 to 20.09.2019 for the purpose of Dividend and Annual General Meeting. etc. SHILPA MEDICARE LTD. - 530549 - Reg. 34 (1) Annual Report
Dear Sir, In accordance with regulation 34 and other regulations of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 we are pleased to inform you that the 32nd Annual General Meeting of Shilpa Medicare Limited is scheduled to be held on Friday the 20th day of September, 2019 at 12:15 P.M. Also please find attached herewith Annual report 2018-19. SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramakant Innani SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant Chaturbhuj Bhutada SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani